APA

Mato A., Fuchs B. D., Heitjan D. F., Mick R., Halpern S. D., Shah P. D., Jacobs S., Olson E. M., Schuster S. J., Ujjani C., Chong E. A., Loren A. W., Miltiades A. N. & Luger S. (20091211). Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies. : Cancer biology & therapy.

Chicago

Mato Anthony, Fuchs Barry D, Heitjan Daniel F, Mick Rosemarie, Halpern Scott D, Shah Payal D, Jacobs Samamtha, Olson Erin M, Schuster Stephen J, Ujjani Chaitra, Chong Elise A, Loren Alison W, Miltiades Andrea N and Luger Selina. 20091211. Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies. : Cancer biology & therapy.

Harvard

Mato A., Fuchs B. D., Heitjan D. F., Mick R., Halpern S. D., Shah P. D., Jacobs S., Olson E. M., Schuster S. J., Ujjani C., Chong E. A., Loren A. W., Miltiades A. N. and Luger S. (20091211). Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies. : Cancer biology & therapy.

MLA

Mato Anthony, Fuchs Barry D, Heitjan Daniel F, Mick Rosemarie, Halpern Scott D, Shah Payal D, Jacobs Samamtha, Olson Erin M, Schuster Stephen J, Ujjani Chaitra, Chong Elise A, Loren Alison W, Miltiades Andrea N and Luger Selina. Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies. : Cancer biology & therapy. 20091211.